There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize...
At 18 Spanish hospitals, when a patient with brain metastasis undergoes surgery, they can donate a tiny part of their brain to the first repository of...
WASHINGTON, Oct. 31, 2023 – Nearly 200 million people around the globe have coronary heart disease, which accounts for about one in every six deaths,...
New research from Memorial Sloan Kettering Cancer Center (MSK) identifies a promising immunotherapy target for acute myeloid leukemia; decodes genetic...
Umbilical venous catheterization (UVC) is vital in neonatal care, as it provides essential intravenous access for preterm infants in neonatal intensive...
This morning we received interim results on Cybin’s Phase 2 trial using its CYB003 psilocybin compound for depression. And they did not disappoint. The...
By KIM BELLARD Larry Levitt and Drew Altman have an op-ed in JAMA Network with the can’t-argue-with-that title Complexity in the US Health Care System...
A national plague of workplace injuries was once a media obsession. Now it’s all but forgotten.
A collaborative study led by researchers from Germans Trias i Pujol Research Institute has revealed the promising possibilities of using an agarose spot...
New York, NY (October 30, 2023)—The Icahn School of Medicine at Mount Sinai will award its 2023 Maria I. New International Prize for Biomedical Research...
In this GEN Learning Lab, Anna Moberg from Cytiva will discuss applications for screening and characterizing antibody and antibody fragments in pure...
SocialClimb a leader in the patient acquisition industry, and IncludeHealth, a leading digital musculoskeletal (MSK) solution provider.announced a partnership...
Companies introduce Siemens Industrial Copilot, a generative AI-powered assistant designed to enhance human-machine collaboration and boost productivity....
mRNA is a new field in medicine, but has unwanted side effects including inflammation. And Noxopharm is the only ASX ... Read More The post mRNA...
Despite recent rounds of tech layoffs and a still-rising interest rate environment, the future looks bright for commercial real estate in the Raleigh-Durham...
Triplebar announced $20M in new financing to expand the biotechnology company’s product portfolio in food and biopharmaceuticals Synthesis Capital led...